↓ Skip to main content

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
13 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Published in
Journal for Immunotherapy of Cancer, October 2018
DOI 10.1186/s40425-018-0421-z
Pubmed ID
Authors

Bin Zhao, Hong Zhao, Jiaxin Zhao

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 15%
Student > Ph. D. Student 8 15%
Student > Postgraduate 7 13%
Student > Bachelor 6 11%
Professor 3 5%
Other 10 18%
Unknown 13 24%
Readers by discipline Count As %
Medicine and Dentistry 23 42%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Biochemistry, Genetics and Molecular Biology 3 5%
Immunology and Microbiology 2 4%
Business, Management and Accounting 1 2%
Other 3 5%
Unknown 19 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2018.
All research outputs
#4,253,783
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,128
of 3,422 outputs
Outputs of similar age
#78,949
of 354,905 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#17
of 39 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,422 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,905 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.